NUTLEY, N.J., May 2 /PRNewswire/ -- Two Roche employees were recognized for their significant contributions to industry in New Jersey at the 34th Annual TWIN Awards Dinner held May 1, 2008. Honored were Jennifer Dudinak, Pharm.D., group director, Oncology, Drug Regulatory Affairs, and Sherrie Pietranico-Cole, Ph.D., research leader, Discovery Chemistry.
"These individuals exemplify the best and brightest at Roche. They have made outstanding contributions to the company's success, and to the health care industry as a whole," said George Abercrombie, president and CEO of Hoffmann-La Roche Inc., adding that the 2008 awardees join the 79 Roche pharmaceutical employees recognized since TWIN began 34 years ago.
TWIN, which stands for Tribute to Women and INdustry, is sponsored by the YWCA of Bergen County to recognize women who have achieved responsible managerial, executive or professional positions and have made noteworthy contributions to their industries.
Jennifer Dudinak, Pharm.D., is group director of Oncology in Drug Regulatory Affairs, which is the key interface between Roche and health authorities, such as the U.S. Food and Drug Administration (FDA). She leads a team responsible for overseeing the regulatory approval process for promising new cancer drugs or new indication on existing drugs that have completed the clinical trial phase. She also was recently appointed as the Pharmaceutical Development Regulatory (PDR) Partner to the company's Oncology Disease Biology Area team.
"Other TWIN winners have been tremendous role models for me, so to receive this award is very humbling," she said.
Dr. Dudinak joined Roche in 1997 as part of the Roche/Rutgers
Post-Doctoral Fellowship Program and in 1999 became part of the PDR
management team. She has worked in all phases of drug development leading
several investigational new drug and global dossiers for new and
supplemental indications. She also served as Inte
Copyright©2008 PR Newswire.
All rights reserved